FDA Inspection
Park Avenue CompoundingPark Avenue Compounding – FDA Inspection, Sep 23, 2025
Record Details
This FDA Inspection record concerns Park Avenue Compounding, with an inspection on September 23, 2025, issued by the Kansas City District Office, covering human drugs.
View Company Profile
ID · 77bfd8ca-b181-4a93-ad1c-d39b4ce7befb
Inspection Facts
- Inspection number
- 1283044
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.165(d)Acceptance criteria for sampling & testing
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.42(c)(10)(iii)Air Supply
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.65(a)Equipment construction - reactive surfaces
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Park Avenue Compounding
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 8, 2024 | OAI | Drug Quality Assurance | |
| August 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 5, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Park Avenue Compounding
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.